Xanthan gum appears in ingredient lists across thousands of packaged foods, gluten-free products, and clinical thickeners for dysphagia—yet its long-term intestinal effects in mammals have been poorly characterized. New animal data now suggest that routine dietary exposure to this ubiquitous additive may not be as inert as regulators and food manufacturers have assumed.
Over ten weeks, adult Wistar rats received xanthan gum at three dose levels. Regardless of dose, all supplemented groups showed elevated colonic lymphocyte infiltration—a histological marker of mucosal immune activation. The pro-inflammatory cytokines IL-1β and TNF-α were altered compared to controls, and two tight-junction proteins governing intestinal barrier integrity, Claudin-2 and ZO-1, were upregulated. On the microbiome side, the broad Firmicutes-to-Bacteroidetes ratio remained stable, but the phylum Elusimicrobiota expanded noticeably—a lesser-studied taxon whose functional role in human gut ecology is still being characterized. The researchers connect these intestinal findings to the clinical observation that xanthan gum supplementation in neonates has been linked to necrotizing enterocolitis, proposing a mechanistic pathway through barrier disruption and cytokine dysregulation.
This work carries genuine relevance for health-conscious adults, but it demands careful contextualizing. The study is entirely rodent-based, and translating dose-response relationships from Wistar rats to human daily exposure levels is non-trivial—especially since xanthan gum consumption from food is typically far lower and more intermittent than in a controlled gavage model. The simultaneous upregulation of both Claudin-2 (which increases paracellular permeability) and ZO-1 (a barrier-reinforcing scaffold protein) is mechanistically paradoxical and warrants deeper investigation. Crucially, the study lacks human or ex-vivo validation, and effect sizes in colon inflammation are described as mild. Taken alongside the existing literature flagging xanthan gum's pro-inflammatory potential, this is confirmatory rather than paradigm-shifting—but it meaningfully strengthens the preclinical case for revisiting how this additive is categorized in long-term dietary risk assessments.
